| GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance (NCT04731272) | University of Pennsylvania | 2021-07-16 |
| Hypoglycemia and Glucagon Response in CF (NCT05700604) | Marmara University | 2020-01-01 |
| Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI) (NCT03551691) | Children's Hospital of Philadelphia | 2018-08-07 |
| Pancreatic Exocrine Insufficiency After Bariatric Surgery (NCT03279653) | Umraniye Education and Research Hospital | 2017-09-01 |
| Equivalence Study to Compare Two Strengths of Creon in China (NCT03450772) | Abbott | 2017-08-31 |
| MRI to Characterize and Predict CF Liver Disease in PUSH Cohort (NCT02979340) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-01-27 |
| PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer (NCT02985801) | Massimo Raimondo, M.D. | 2016-12-01 |
| Effect of Chronic Incretin-based Therapy in Cystic Fibrosis (NCT01879228) | University of Pennsylvania | 2013-06-01 |
| Beta-cell Response to Incretin Hormones in Cystic Fibrosis (NCT01851694) | University of Pennsylvania | 2013-05-01 |
| Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis (NCT01710644) | Nordmark Arzneimittel GmbH & Co. KG | 2013-05-01 |
| Pancreatic Insufficiency Secondary to Tobacco Exposure (NCT01988350) | Emory University | 2013-05-01 |
| Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency (NCT01012908) | Azidus Brasil | 2010-03-01 |
| Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis (NCT01144507) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2010-01-12 |
| Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF) (NCT00880100) | Forest Laboratories | 2009-04-01 |
| Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis (NCT00705978) | Abbott Products | 2008-06-01 |
| Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI) (NCT00513682) | Forest Laboratories | 2007-07-01 |
| Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI (NCT00406536) | Avanti Polar Lipids, Inc. | 2007-01-01 |
| Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis (NCT00432861) | Digestive Care, Inc. | 2007-01-01 |
| Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis (NCT00763412) | Arbelaez, Ana Maria | 2006-11-01 |
| Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea (NCT00572975) | Children's Hospital of Philadelphia | 2006-08-01 |
| Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency (NCT00095732) | Anthera Pharmaceuticals | 2004-06-01 |